Validation of a German translation of a dysphagia screening tool for stroke patients
German Translation and Validation of the Barnes-Jewish-Hospital Stroke Dysphagia Screen (BJH-SDS)
This study is testing a German version of a quick screening tool to see if it can accurately identify swallowing problems in stroke patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 570 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | University of Giessen Academic / other |
| Locations | 1 site (Giesen, Hesse) |
| Trial ID | NCT06497790 on ClinicalTrials.gov |
What this trial studies
This study aims to validate the German translation of the Barnes-Jewish Hospital Stroke Dysphagia Screen (BJH-SDS) by assessing its sensitivity, specificity, interrater reliability, and criterion validity among stroke patients. The BJH-SDS is a quick screening tool designed to identify dysphagia, a common complication following a stroke that can lead to serious health issues like aspiration pneumonia. If the translation is validated, it will also be tested on general neurological patients to ensure its broader applicability. The study will involve screening patients in specific neurology departments and stroke units across several hospitals in Germany.
Who should consider this trial
Good fit: Ideal candidates for this study are acute stroke patients admitted to the neurology department or stroke unit.
Not a fit: Patients with a history of stroke, pre-existing dysphagia, or conditions associated with dysphagia may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the early detection and management of dysphagia in stroke patients, potentially reducing complications and improving patient outcomes.
How similar studies have performed: Other studies have shown success with similar dysphagia screening tools, indicating that this approach is both validated and effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All stroke patients in the neurology department of the Lahn-Dill Clinic in Wetzlar and the stroke unit of the Bürgerhospital in Friedberg and the neurologic ICU of the University Hospital in Giessen are to be screened with the BJH-SDS-G after appropriate information has been provided. Exclusion Criteria: * Exclusion criteria are a lack of informed consent, contraindications to an FEES examination, a history of stroke, pre-existing dysphagia or a disease that may be associated with dysphagia (e.g. ENT tumors, Parkinson's disease, neuromuscular diseases).
Where this trial is running
Giesen, Hesse
- University Hospital Giessen and Marburg, Campus Giessen — Giesen, Hesse, Germany (Recruiting)
Study contacts
- Principal investigator: Samra Hamzic, Dr. — University of Giessen
- Study coordinator: Tobias Braun, PD MD
- Email: tobias.braun@neuro.med.uni-giessen.de
- Phone: +49 6441793517
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.